Drug Industry

Order of the National Green Tribunal regarding an illegal cracker unit in Thanjavur district, Tamil Nadu, 29/05/2025

Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …

Experimenting with the young

The inquiry committee report on the anti-cervical cancer vaccine study project finds serious ethical violations. (Editorial)

Killing a mouse could get you 5 years in jail

Scientists Wary Of Animal Welfare Act Draft Hyderabad: Punishment for causing the death of a person in an accident is an imprisonment of up to two years as per IPC section 304 (A). But kill a mouse or even injure it and you will have to serve upto five years …

A united front

Pharmaceutical firms should come clean to tackle drug contamination. (Editorial)  

DCGI: Cancel licences of those exporting banned malaria drug

The oral single drug formulation of Artemisinin, having potential to become resistant to malaria, has been withdrawn from India. However, some manufacturers continue to produce and export it as a mono therapy. On Tuesday, the Drug Controller General of India (DCGI) asked the state drug controllers to cancel the licence …

Cepa set to get Japan nod by June end

Mumbai Japanese Parliament is likely to give approval to the Comprehensive Economic Partnership Agreement (Cepa) with India by the end of June this year, Japanese ambassador to India Akitaka Saiki said. India and Japan signed a comprehensive economic partnership agreement in February which is expected to give greater market access …

Ministers Panel to Look into FDI in Pharma Sector

CCEA move follows spate of takeovers of Indian cos by multinationals in recent past The government has ordered constitution of an interministerial group to review India

Glaxo in talks to buy BEs vaccine division

Hyderabad-based Biological E makes paediatric & adult vaccines GlaxoSmithKline Biologicals, a division of global drug giant Glaxo, is in talks with the Hyderabad-based Biological E Ltd (BE) to purchase its vaccines division, people familiar with the discussions said. This division produces and markets a range of paediatric and adult vaccines …

Govt Plans to Make Public Details of Patented Drugs

Move to help Indian cos challenge patent holders & sell low-cost version of high-priced drugs The government will make public details of every medicine patented in the country to bring transparency

Sun Pharma, Merck in JV to develop, mkt generics

Mumbai: US-based pharma biggie Merck and Mumbaibased Sun Pharma have entered into a strategic collaboration to jointly develop, manufacture and commercialize new combinations of innovative branded generics (affordable versions sold under a brand name) in emerging markets. The joint venture, with

No Additional Norms to Issue Compulsory Drug Licences

The government has decided to retain the flexibility it has in issuing compulsory licences for patented drugs in case of public health emergency and not issue specific guidelines on when it can act.

Non-Compliance with Disclosure Norms on Patents May Bring Trouble for Pharma Cos

Several global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India, making them vulnerable to penalties and potentially allowing local firms to make and sell low-cost version of their drugs, local patent lawyers said. To ensure that the patents granted in …

Govt to draft first ever policy to regulate antibiotics use

The Government Medical College and Hospital, Sector 32, (GMCH-32), will celebrate World Health Day on Thursday keeping in view this year

Fix the antibiotics pipeline

The framework for antibiotic discovery, development and approval is broken — only four new classes of antibiotics have been launched in the past 40 years. The World Health Organization forecasts a disaster due to the rapid, unchecked increase in antimicrobial resistance and has just announced a policy to combat its …

Patient Watching

A large programme to record adverse effects of drugs brings hopeOn Guard... Many Indians report reactions to drugs every year

Strategies and practices in off-label marketing of pharmaceuticals: A retrospective analysis of whistleblower complaints

Despite regulatory restrictions, off-label marketing of pharmaceutical products has been common in the US. However, the scope of off-label marketing remains poorly characterized. We developed a typology for the strategies and practices that constitute off-label marketing.

Regulate use of drugs, say scientists

Moga: Scientists have called upon medical scientists and pharmacists in particular to regulate the use of drugs to minimise their side affects and improve the quality of life. They were addressing pharmacists and young scientists in the two-day national seminar on

Licence revived, production halted

LICENCES of public-sector, vaccine-manufacturing units were restored more than a year ago. But the units are yet to resume supply of vaccines to the Centre’s Universal Immunisation Programme, and it will not happen any time soon if one were to believe activists. The Central Research Institute (CRI) at Kasauli in …

High Court Stays Winding Up Order Against Wockhardt

The court has asked Wockhardt to deposit . 115 crore by May 3 as a sign of its solvency Wockhardt won temporary reprieve in the Bombay High Court as a division bench conditionally stayed its winding-up until May 3. The bench required Wockhardt to deposit . 115 crore by this …

Why is India losing its anti-cancer wonder plant?

RAMPANT ILLEGAL harvesting and trade in a wild plant endemic to the Western Ghats called narakya (Mappia foetida), which has anti-cancer properties, has made it an endangered species. The tree is being exploited clandestinely in the domestic market and also shipped abroad. The profit potential is enormous, as the alkaloid …

Real R&D cost much lower than what pharma cos claim

New Delhi: Talk to a drug industry executive about high medicine prices and they throw back the $1.3 billion the industry spends on average on research and development (R&D;) of a single drug. In a recent analysis bound to deflate this justification for high pricing, two health economists have demonstrated …

  1. 1
  2. ...
  3. 31
  4. 32
  5. 33
  6. 34
  7. 35
  8. ...
  9. 73

IEP child categories loading...